|
CME Information
This activity is jointly provided by Global Education Group and Pacific Coast Reproductive Society.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must attend the conference and complete a program evaluation. Certificates of credit will be emailed to learners 3-4 weeks after the conclusion of the conference.
- At the conclusion of the meeting, all eligible attendees will receive an email to complete the program evaluation.
- PCRS provides the post-test to attendees three weeks after the conclusion of the event to evaluate the retention of the knowledge gained by attending the sessions. Attendees must complete the post-test to earn CME.
Target Audience
Practicing physicians, physicians in training, and scientists in training in the field of reproductive medicine representing:
- Andrology/Male Infertility
- Reproductive Endocrinology
- Obstetrics and Gynecology
Physician team members and allied health professionals representing:
- Complementary Healthcare
- Mental Health
- Nursing
- Reproductive Biologists/Laboratory Specialists
- Outside Agencies
- Third-Party Agencies
- Genetic Laboratories
Statement of Need/Program Overview
The Pacific Coast Reproductive Society annual meeting is designed to provide Continuing Medical Education (CME) to physicians and allied healthcare professionals. The Pacific Coast Reproductive Society’s (PCRS) global commitment to exceptional patient care is embodied in the continuing medical education of physicians, their teams, and allied professionals. Promoting the highest standards of clinical practice, patient safety, and improved patient outcomes, related to the treatment of infertility, is consistent with the principles and goals of PCRS.
The Pacific Coast Reproductive Society’s CME program is based on the integration of clinical practice, scientific research, and education in Assisted Reproductive Technologies (ART) Consistent with these values, the following goals of PCRS/CME are intended to:
- Cultivate an atmosphere for thinking differently, unconventionally, or from new perspectives
- Offer thought-provoking programming enabling physicians, their teams, and allied health care professionals to provide superior medical care for patients
- Update or reinforce knowledge of current concepts, techniques, or practices
- Promote innovation in clinical practice and research
- Foster the integration of advances in relevant scientific and clinical research ensuring clinicians access to timely and relevant information
- Enable clinicians to recognize, practice, discuss, and apply new concepts, technologies, or practices, as they relate to the management of infertility in their specific area of clinical practice or research
- Further the identification and recognition of ethical, psychological, and cultural patient concerns
- Provide a forum for clinicians, academicians, and other professionals in allied fields to create or renew collegial and collaborative relationships that enhance their effectiveness, promote high standards of clinical practice, patient safety, and improved patient outcomes
- Facilitate a career-long continuum of medical education.
- PCRS accomplishes these goals through its Annual Meeting, which includes multiple disciplines (in reproductive medicine) in an educational program attracting regional, national, and international participants.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the updated evidence and recommendations on screening and treating subclinical hypothyroidism in women diagnosed with infertility
- Discuss how to implement management for patients with PCOS when not trying to conceive and for fertility treatment
- Analyze complex reproductive health cases
- Assess the clinical utility and validity of emerging technologies in human embryo testing
- Review factors related to sperm that influence fertilization, embryo development, live birth and future generations Explain how emerging technologies and redesigned workflows are addressing bottlenecks in fertility care
Faculty
View Presenters Here
Program Agenda
Please visit the 2026 Annual Meeting Schedule
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Pacific Coast Reproductive Society. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live event for a maximum of 19 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*ACCME credit hours subject to change
Nursing Continuing Education
Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 19 contact hours including 0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
*ANCC contact hours subject to change
National Society of Genetic Counselors
The National Society of Genetic Counselors (NSGC) has authorized Global Education Group to offer up to 2.2 CEUs or 22 Category 1 contact hours for the activity PCRS 2026 Annual Meeting. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.
American Board of Bioanalysis (ABB)/ Professional Enrichment Educational Renewal (PEER)
Pre-approved by ABB/PEER for up to 11.5 hours of continuing education credit.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Instructions for Obtaining Credit
In order to receive credit for this activity, the participant must attend the conference, complete the post-test with a score of 70% or better and complete a program evaluation. Certificates of credit will be emailed to learners 3-4 weeks after the conclusion of the conference.
- At the conclusion of the meeting, all eligible attendees will receive an email to complete the post-test and program evaluation.
- *NSGC members must include their User ID to receive credit and complete the requirements by May 15, 2026. Please utilize these instructions to help find or create a free or paid NSGC User ID.
- **ABB members that reside in Florida must include their state license number and complete the requirements by April 15, 2026 to receive credit.
Fee Information & Refund/Cancellation Policy
Please see the main webpage for our Cancellation Policy
Disclosure of Relevant Financial Relationships
Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
|
Name of Faculty or Presenter
|
Relevant Relationships Disclosed to Learners
|
|
Rawan Awwad
|
Employee: Fairfax EggBank (full-time) Consulting Fee (e.g., Advisory Board): Mavin Clinic, LabCorp
|
|
Kurt Barnhart
|
Nothing to disclose
|
|
Christina Boots
|
Nothing to disclose
|
|
Alleigh Boyd
|
Nothing to disclose
|
|
Pranam Chatterjee
|
Nothing to disclose
|
|
Pierre Comizzoli
|
Nothing to disclose
|
|
Joseph Conaghan, PhD, HCLD
|
Consulting Fee (e.g., Advisory Board): Nexpring Health Speakers' Bureau: Nexpring Health
|
|
Susan Crockin, JD
|
Nothing to disclose
|
|
Kate Devine
|
Nothing to disclose
|
|
Jamie Feingold
|
Consulting Fee (e.g., Advisory Board): EMD Serono
|
|
Eduardo Hariton, MD, MBA
|
Consulting Fee (e.g., Advisory Board): Alife Health, Cercle Al, Evernow Inc., Fertilidad Integral, Inti Labs, Levy Health, Modern Fertility/ Ro, Oova Stock Option Holder (Individual Stocks, Stock Options; Diversified Mutual Funds do not need to be disclosed): Alife Health, Cercle AI, Evernow Inc., Fertilidad Integral, Inti Labs, Levy Health, Modern Fertility/ Ro, Oova Other: Board Member for Granata Bio, PozitIVF
|
|
Micah Hill
|
Nothing to disclose
|
|
Rebecca "Bec" Holmes, PhD, HCLD
|
Nothing to disclose
|
|
Jim Hotaling
|
Owner/Co-Owner Founder/Co-Founder: paterna bio, firmtech, Consulting Fee (e.g., Advisory Board): maximus, carrot, repronovo, coloplast Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): carrot, maximus, repronovo, firmtech, inherent (path fertility), paterna
|
|
Kristin Lyerly
|
Nothing to disclose
|
|
Jenna Miller, MS, CGC
|
Employee: CooperSurgical Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): CooperSurgical
|
|
Bruce Pier
|
Nothing to disclose
|
|
Malavika Prabhu, MD
|
Consulting Fee (e.g., Advisory Board): BabyList Inc Stock Option Holder (Individual stocks/ Stock Options; diversified mutual funds do not need to be disclosed): Roon Royalty: UpToDate, Inc.
|
|
Alexander Quaas, MD, PhD
|
Speakers' Bureau: Ferring Pharmaceuticals
|
|
Sarah Deepthi Ramaiah
|
Nothing to disclose
|
|
Hayley Rapp, DNP, APRN, WHNP-BC, CPPS
|
Nothing to disclose
|
|
Ursula Rocha, MSN, APRN, WHNP-BC, C-RHI
|
Nothing to disclose
|
|
Phillip Romanski, MD, MSc
|
Nothing to disclose
|
|
Denny Sakkas, PhD
|
Nothing to disclose
|
|
Chevis Shannon
|
Nothing to disclose
|
|
Susan Strellec, MBA, MPAS, PA-C
|
Nothing to disclose
|
|
Hugh Taylor
|
Contracted Research (Principal Investigators must provide information, even if received by the institution): AbbVie, Organon
|
|
Amber Kaplun (CGC)
|
Consulting Fee (e.g., Advisory Board): LabCorp Women's Health and Genetics
|
The planners and managers have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group have no relevant financial relationships to disclose. The planners and managers at Pacific Coast Reproductive Society have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Pacific Coast Reproductive Society do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
|